Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/1995
03/29/1995EP0644773A1 Anti-aids immunomodulator complex
03/29/1995EP0644769A1 Biologically active peptides having n-terminal substitutions
03/29/1995EP0644758A1 Use of fatty acids, e.g. z-hydroxymystic acids, as antiviral agents
03/29/1995EP0644716A1 Medical uses of trioxolane and diperoxide compounds
03/29/1995CN1100719A 3-bromo- and 2-nitroxy derivatives of 3-bromo- and 3,3-dibromo-4-oxo, zaetidines, processes for the preparation thereof and use thereof
03/29/1995CN1100656A Improved meningococcal polysaccharide conjugate vaccine
03/28/1995US5401875 2-aminocarboxylic acids and their derivatives, processes for their preparation and their use as medicaments
03/28/1995US5401863 9-amino-7-(substituted)-6-demethyl-6-deoxytetracyclines
03/28/1995US5401841 3-vinyl-substituted
03/28/1995US5401729 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
03/28/1995US5401727 Process for enhancing the resistance of aquatic animals to disease
03/28/1995CA1334977C Mono-iodopropargyl esters of dicarboxylic anhydrides and their use as antimicrobial agents
03/28/1995CA1334973C Amine derivatives, processes for preparing the same and fungicides containing the same
03/28/1995CA1334970C Crystalline .beta.-lactam hydrate
03/28/1995CA1334949C Antimicrobial agent, fr 109615 and production thereof
03/28/1995CA1334941C Cloning and expression of a host-protective immunogens of ibdv
03/28/1995CA1334934C Antibacterial composition for oral administration
03/25/1995CA2132791A1 Azole compounds, their production and use
03/23/1995WO1995007995A2 Adeno-associated viral (aav) liposomes and methods related thereto
03/23/1995WO1995007994A2 Recombinant alphavirus vectors
03/23/1995WO1995007987A2 Novel proteins/polypeptides and cotransfection plasmids and live recombinant carriers therefor
03/23/1995WO1995007986A1 Pharmaceutical compositions containing ecotin and homologs thereof
03/23/1995WO1995007934A2 Il8 inhibitors
03/23/1995WO1995007920A1 Nucleotide analogs
03/23/1995WO1995007919A1 Method for dosing therapeutic compounds
03/23/1995WO1995007902A1 Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof
03/23/1995WO1995007901A1 Substituted tetronic acids useful for treating hiv and other retroviruses
03/23/1995WO1995007890A1 Substituted pyridines, process for producing them and their use as pesticides and fungicides
03/23/1995WO1995007878A1 Novel compounds
03/23/1995WO1995007718A2 Purine nucleoside phosphorylase gene therapy for human malignancy
03/23/1995WO1995007715A1 Cd8+ cell antiviral factor
03/23/1995WO1995007706A1 The semaphorin gene family
03/23/1995WO1995007696A1 Pharmaceutical composition of hiv-protease inhibitors
03/23/1995WO1995007692A1 Viscous surfactant emulsion compositions
03/23/1995WO1995005467A3 Chitinase, dna coding therefor and plants containing same
03/23/1995WO1995005393A3 Lipopolysaccharide-binding and neutralizing peptides
03/23/1995DE4409671C1 Use of 2-methylamino-2-phenylcyclohexanone for the treatment of bacterial, fungal, viral or protozoal infections and for immunomodulation
03/23/1995DE4331670A1 Antisense oligonucleotides against HSV-1 and the preparation thereof
03/23/1995CA2171869A1 Novel proteins/polypeptides and cotransfection plasmids and live recombinant carriers therefor
03/23/1995CA2171868A1 Method for dosing therapeutic compounds
03/23/1995CA2171318A1 Adeno-associated viral (aav) liposomes and methods related thereto
03/23/1995CA2170030A1 Pharmaceutical compositions containing ecotin and homologs thereof
03/23/1995CA2168757A1 Substituted tetronic acids useful for treating hiv and other retroviruses
03/23/1995CA2167412A1 Pharmaceutical composition of hiv-protease inhibitors
03/22/1995EP0644201A1 Derivatives of gpl60 and vaccines based on gpl60 or a derivative thereof, containing an adjuvant
03/22/1995EP0644199A1 Cyclic antimicrobial peptides and preparation thereof
03/22/1995EP0643972A2 Use of recombinant colony stimulating factor-1 for the preparation of a medicament for cytomegalovirus infections and leukopenia
03/22/1995EP0643970A2 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide for use in medical treatment of humans
03/22/1995EP0643775A1 Therapeutic compositions
03/22/1995EP0643770A1 Helicobacter pylori proteins useful for vaccines and diagnostics
03/22/1995EP0643713A1 Pyrrolo(1,2-b)-(1,2)-benzothiazin-10-one and its use as an antimicrobial
03/22/1995EP0643586A1 Compositions useful in diagnosis and prophylaxis of lyme disease
03/22/1995EP0643585A1 A method for using lipoprotein associated coagulation inhibitor to treat sepsis
03/22/1995EP0643583A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy
03/22/1995EP0643559A1 Diphtheria toxin receptor-binding region
03/22/1995EP0449958B1 Meningococcal class 1 outer-membrane protein vaccine
03/22/1995CN1100428A Improved meningococcal polysaccharide conjugate vaccine
03/22/1995CN1100421A Process for preparation of a pharmaceutical composition containing a triazole derivative
03/22/1995CN1100413A Urethanes and ureas that induce cytokine production
03/22/1995CN1100303A L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents
03/21/1995US5399741 DNA gyrase inhibitors, process for their manufacture and pharmaceutical preparations containing same
03/21/1995US5399723 Bactericide active against methicillin resistant Staphylococcus aureus
03/21/1995US5399686 Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate
03/21/1995US5399555 Viricides against retroviruses, especially HIV
03/21/1995US5399552 Antibiotic peptides bearing aminoalkylthioether moieties
03/21/1995US5399341 Use of cytokin-containing aerosols and the cytokin-containing aerosols
03/21/1995CA2003198C Aqueous ophthalmic solutions and method for preserving same
03/21/1995CA1334846C Lipid derivatives of antiviral nucleosides, liposomal incorporation and method of use
03/16/1995WO1995007354A1 Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains
03/16/1995WO1995007271A1 Substituted oxazine and thiazine oxazolidinone antimicrobials
03/16/1995WO1995007257A1 Difluoro statone antiviral analogs
03/16/1995WO1995007101A2 Living salmonella vaccine
03/16/1995WO1995007086A1 Nucleosides with anti-hepatitis b virus activity
03/16/1995WO1995007084A1 Blocking the accumulation of germs on human cells
03/16/1995WO1995003415A3 Epstein-barr virus dna sequences encoding a diagnostically relevant virus capsid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic tests
03/16/1995CA2171197A1 Blocking the accumulation of germs on human cells
03/15/1995EP0643074A2 Viral infection and proliferation inhibitors
03/15/1995EP0643069A1 2'-deoxy-2'-fluorocoformycin and stereoisomers thereof
03/15/1995EP0643061A1 Novel cephalosporin antibiotics and processes for preparation thereof
03/15/1995EP0643058A1 Crystals of an antimicrobial compound
03/15/1995EP0643044A1 Bis-biguanide compound useful as a disinfectant
03/15/1995EP0642796A1 Salmonella live vaccines
03/15/1995EP0642589A1 Method and reagent for inhibiting viral replication
03/15/1995EP0642582A1 Hybrid siv/hiv-1 viral vectors and monkey model for aids
03/15/1995EP0642581A1 Clostridium perfringens vaccines
03/15/1995EP0642513A1 Indolocarbazole imides and their use
03/15/1995EP0642355A1 Combined vaccines comprising hepatitis b surface antigen and other antigens
03/15/1995EP0642351A1 New pharmaceutical uses of krill enzymes
03/15/1995EP0642342A1 Selective cell inactivation in blood
03/15/1995EP0394333B1 Uses of sulphated sugars
03/15/1995CN1100104A New polypeptide compound and a process for preparation thereof
03/15/1995CN1100100A 1-beta-methy1-2-thiolic carbapenem derivatives
03/15/1995CN1100090A Amine derivatives of oxo- and hydroxy-substituted hydrocarbons
03/15/1995CA2131759A1 Valine-containing pseudopeptides with antiviral activity
03/15/1995CA2131758A1 Pseudopeptides with antiviral activity
03/14/1995US5397794 Treatment of retrovirus
03/14/1995US5397701 Azido-substituted fatty acid analog enzyme substrates
03/14/1995US5397694 For treatment of periodontal disease
03/14/1995US5397569 Method of treating Infectious Bursal Disease Virus infections
03/14/1995CA2131760A1 Nucleic acid-binding oligomers possessing c-branching for therapy and diagnostics
1 ... 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 ... 1798